Eli Lilly and Company - Net Interest Income

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Millions.

The item "Net-Interest-Income" stands at -699.40 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Eli Lilly and Company's third quarter result of -114.60 Million USD for the item "Net Interest Income" represents an increase of 45.17 percent compared to it's second quarter result.

Also, Eli Lilly and Company's third quarter result of -114.60 Million USD for the item "Net Interest Income" represents an increase of 20.91 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Eli Lilly and Company's third quarter result of -699.40 Million USD for the item "Net Interest Income" represents an increase of 4.15 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -180.70 Million United States Dollars compared to the value the year prior.
The 1 year change is -180.70 Million United States Dollars.
The 3 year change is -415.10 Million United States Dollars.
The 5 year change is -373.50 Million United States Dollars.

The Serie's long term average value is -359.61 Million United States Dollars. It's latest available value, on 09/30/2025, is -339.79 Million United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +30.30 Million.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2019, to it's latest available value, on 09/30/2025, is -643.50 Million.